Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 8986-8995
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8986
Figure 3
Figure 3 A non-microbial approach for Helicobacter pylori-associated gastritis as well as gastric cancer. Simply removing Helicobacter pylori (H. pylori) can contribute to gastric cancer prevention in some patients. For example, H. pylori eradication suppressed the metachronous occurrence of gastric cancer in patients who underwent endoscopic submucosal dissection, whereas insignificant outcomes were noted in general eradication. Supplementation or treatment with long-term phytoceuticals or other agents were proven to be very efficacious in the prevention of H. pylori-associated gastric carcinogenesis. These treatment strategies are supported by the clear mechanisms of anti-inflammation, anti-oxidation, and anti-mutagenesis associated with their use.